Fig. 3.

Early initiation of treatment permits the maintenance of anti measles and tetanus antibody titers above protective threshold in HIV-1 vertically-infected children. (A–C) Box plot analyses on the measles-, tetanus-, and pneumococcus-specific antibody titers. (D) Gp41-specific antibody detection. (E and F) Percentages of patients with measles- and tetanus-specific antibody titers above protective threshold. White bars, positive response; gray bars, negative response. (G and H) Scatter plot analyses on the measles- and tetanus-specific antibody titers in relation to years from vaccination or boost; the line indicates protective threshold. Shown are data from single time point sampling.